Literature DB >> 23987220

Improved estimation of the health and economic burden of chronic disease risk factors in Manitoba.

H Krueger1, D Williams, A E Ready, L Trenaman, D Turner.   

Abstract

INTRODUCTION: There are analytic challenges involved with estimating the aggregate burden of multiple risk factors (RFs) in a population. We describe a methodology to account for overlapping RFs in some sub-populations, a phenomenon that leads to "double-counting" the diseases and economic burden generated by those factors.
METHODS: Our method uses an efficient approach to accurately analyze the aggregate economic burden of chronic disease across a multifactorial system. In addition, it involves considering the effect of body weight as a continuous or polytomous exposure that ranges from no excess weight through overweight to obesity. We then apply this method to smoking, physical inactivity and overweight/obesity in Manitoba, a province of Canada.
RESULTS: The annual aggregate economic burden of the RFs in Manitoba in 2008 is about $1.6 billion ($557 million for smoking, $299 million for physical inactivity and $747 million for overweight/obesity). The total burden represents a 12.6% downward adjustment to account for the effect of multiple RFs in some individuals in the population.
CONCLUSION: An improved estimate of the aggregate economic burden of multiple RFs in a given population can assist in prioritizing and gaining support for primary prevention initiatives.

Entities:  

Keywords:  chronic disease; obesity; physical inactivity; population attributable fraction; risk factors; tobacco smoking

Mesh:

Year:  2013        PMID: 23987220

Source DB:  PubMed          Journal:  Chronic Dis Inj Can        ISSN: 1925-6515


  13 in total

1.  Regional variations in the economic burden attributable to excess weight, physical inactivity and tobacco smoking across British Columbia.

Authors:  H Krueger; J M Koot; D P Rasali; S E Gustin; M Pennock
Journal:  Health Promot Chronic Dis Prev Can       Date:  2016-04       Impact factor: 3.240

2.  The economic burden of cancers attributable to tobacco smoking, excess weight, alcohol use, and physical inactivity in Canada.

Authors:  H Krueger; E N Andres; J M Koot; B D Reilly
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

3.  Variation across Canada in the economic burden attributable to excess weight, tobacco smoking and physical inactivity.

Authors:  Hans Krueger; Joshua Krueger; Jacqueline Koot
Journal:  Can J Public Health       Date:  2015-04-30

4.  The economic benefits of risk factor reduction in Canada: tobacco smoking, excess weight and physical inactivity.

Authors:  Hans Krueger; Donna Turner; Joshua Krueger; A Elizabeth Ready
Journal:  Can J Public Health       Date:  2014-03-18

5.  Mortality, hospital days and treatment costs of current and reduced sugar consumption in Israel.

Authors:  Gary M Ginsberg
Journal:  Isr J Health Policy Res       Date:  2017-01-10

6.  Investing in a healthy lifestyle strategy: is it worth it?

Authors:  Tarik Benmarhnia; Pierre-Alexandre Dionne; Éric Tchouaket; Alvine K Fansi; Astrid Brousselle
Journal:  Int J Public Health       Date:  2016-09-01       Impact factor: 3.380

7.  Don't Change Much.

Authors:  H Krueger; S L Goldenberg; J Koot; E Andres
Journal:  Am J Mens Health       Date:  2016-10-04

8.  The economic burden of inadequate consumption of vegetables and fruit in Canada.

Authors:  John Paul Ekwaru; Arto Ohinmaa; Sarah Loehr; Solmaz Setayeshgar; Nguyen Xuan Thanh; Paul J Veugelers
Journal:  Public Health Nutr       Date:  2016-11-07       Impact factor: 4.022

9.  The economic burden of not meeting food recommendations in Canada: The cost of doing nothing.

Authors:  Jessica R L Lieffers; John Paul Ekwaru; Arto Ohinmaa; Paul J Veugelers
Journal:  PLoS One       Date:  2018-04-27       Impact factor: 3.240

10.  Temporal changes in diet quality and the associated economic burden in Canada.

Authors:  Léon Nshimyumukiza; Jessica R L Lieffers; John Paul Ekwaru; Arto Ohinmaa; Paul J Veugelers
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.